http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2015110985-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2015110985-A
titleOfInvention SERIN / THREONIN KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
abstract 1. The compound according to formula I where: X is CH or N; Z is (i) NH (CH) CHRAr, where n is 0 or 1, or (ii) 1-alkyl-4-aryl-pyrrolidin-3 -ylamine or 4-aryl-pyrrolidin-3-ylamine, where alkyl is C1-6alkyl optionally substituted with a phenyl ring, and aryl is optionally substituted phenyl; R4 represents (a) hydrogen, (b) C-C1-6alkyl optionally substituted with one or more hydroxyl or Salkoxy groups, (c) C-Salkenyl optionally substituted with one or more hydroxyl or Salkoxy groups, (g) C- alkynyl with one or more hydroxyl or Salkoksigrupp, (d) C-cycloalkyl, optionally substituted with one or more groups selected from the group consisting of hydroxyl, alkoxy, halogen and C ^ alkyl; (e) a 4-6 membered heterocycle containing 1 or 2 heteroatoms selected from N or O, where the heterocycle is optionally substituted with one or more groups selected from the group consisting of hydroxyl, Salkoxy, C 1-6alkyl and halogen, or (g) 5 A 6-membered heteroaryl containing 1 or 2 heteroatoms selected from N or O, wherein the heteroaryl is optionally substituted with one or more groups selected from the group consisting of hydroxyl, Salkoxy, C1-6alkyl and halogen; Ar is phenyl, pyridinyl or indolyl, optionally substituted with 1-3 groups independently selected from (a) Ca alkyl, (b) Haloalkyl, (c) Salkoxy, (d) Cycloalkyl, (e) halogen, (e) Haloalkoxy, (g) Salkylthio, (e) cyano, (g) benzyl, (h) phenoxy, where benzyl is indicated and phenoxy optionally substituted with halogen, C1-6alkyl or Salkoxy, (i) 4-methylpiperazin-1-yl or (i) heteroaryl selected from the group consisting of pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl and pyrazolyl, wherein said heteroaryl is optionally substituted
priorityDate 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420237462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID37602
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID37602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393786

Total number of triples: 41.